Francesco Bertoni, MD, PhD, on Tumor Suppressor Activity in DLBCL | Blood Cancers Today
Dr. Bertoni and colleagues characterized two small nucleolar RNAs that exert tumor suppressor activity in DLBCL cells.
Dr. Bertoni and colleagues characterized two small nucleolar RNAs that exert tumor suppressor activity in DLBCL cells.
Physicians and medical researchers are increasingly recognizing the importance of a third type of cholesterol known as lipoprotein(a) – or Lp(a). What exactly is Lp(a)?…
A brief episode of anger triggered by a past experience has the potential to increase the risk of stroke by weakening the ability of blood…
Cancer Nursing Today Contributor Fatemeh Youssefi, PhD, RN, OCN, speaks with Kim Marchand, RN, OCN, at the 49th Annual Oncology Nursing Society Congress.
Hosted by Chadi Nabhan, MD, the inaugural HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 3-4 in Chicago.
AbstractBackgroundCombination therapy with immune checkpoint inhibitors (ICIs) and vascular endothelial growth factor inhibitors (VEGFIs) has improved cancer outcomes and is increasingly used. Thes…
The ARASENS study analyzed the efficacy of darolutamide in combination with ADT and docetaxel for the treatment of mHSPC.
Welcome to the 33rd case of the Skeleton Key Group, a team of nephrologists from around the world who build a periodic education package for…
Prefibrotic myelofibrosis is the focus of “SOHO State of the Art Updates and Next Questions.”
An Education Session during ASCO24 will help oncologists foster deeper understanding of the needs of patients and caregivers, especially those from historically marginalized communities.